ELEVANCE HEALTH INC (ELV) Forecast, Price Target & Analyst Ratings

NYSE:ELV • US0367521038

Current stock price

344.76 USD
-1.53 (-0.44%)
At close:
344.76 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELEVANCE HEALTH INC (ELV).

Forecast Snapshot

Consensus Price Target

Price Target
$391.79
+ 13.64% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 15, 2026
Period
Q2 / 2026
EPS Estimate
$6.51
Revenue Estimate
48.749B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
74.29%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$391.79
Upside
+ 13.64%
From current price of $344.76 to mean target of $391.79, Based on 28 analyst forecasts
Low
$335.32
Median
$394.74
High
$516.02

Price Target Revisions

1 Month
-1.91%
3 Months
-1.58%

Price Target Summary

28 Wall Street analysts provided a forecast for the next 12 months for ELV. The average price target is 391.79 USD. This implies a price increase of 13.64% is expected in the next year compared to the current price of 344.76.
The average price target has been revised downward by 1.58% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ELV Current Analyst RatingELV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

ELV Historical Analyst RatingsELV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
74.29%
ELV was analyzed by 28 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about ELV.
In the previous month the buy percentage consensus was at a similar level.
ELV was analyzed by 28 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-24GuggenheimMaintains Buy -> Buy
2026-04-24BarclaysMaintains Overweight -> Overweight
2026-04-23Evercore ISI GroupMaintains In-Line -> In-Line
2026-04-23BairdMaintains Neutral -> Neutral
2026-04-20JefferiesMaintains Buy -> Buy
2026-04-13Truist SecuritiesMaintains Buy -> Buy
2026-04-08Evercore ISI GroupInitiate In-Line
2026-03-11MizuhoMaintains Outperform -> Outperform
2026-02-02Truist SecuritiesMaintains Buy -> Buy
2026-02-02JP MorganMaintains Overweight -> Overweight
2026-01-30BarclaysMaintains Overweight -> Overweight
2026-01-30Wells FargoMaintains Overweight -> Overweight
2026-01-29GuggenheimMaintains Buy -> Buy
2026-01-22GuggenheimMaintains Buy -> Buy
2026-01-08Wolfe ResearchUpgrade Peer Perform -> Outperform
2026-01-07Wells FargoMaintains Overweight -> Overweight
2026-01-05BarclaysMaintains Overweight -> Overweight
2025-12-19Deutsche BankDowngrade Buy -> Hold
2025-12-18Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-11-26TD CowenMaintains Buy -> Buy
2025-11-04MizuhoMaintains Outperform -> Outperform
2025-10-28JP MorganMaintains Overweight -> Overweight
2025-10-23TD CowenMaintains Buy -> Buy
2025-10-22BarclaysMaintains Overweight -> Overweight
2025-10-22Wells FargoMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 15, 2026
Period
Q2 / 2026
EPS Estimate
$6.51
Revenue Estimate
48.749B
Revenue Q2Q
-1.36%
EPS Q2Q
-26.39%
Number of Analysts
23

Next Earnings Revisions

Revenue (1 Month)
-0.05%
Revenue (3 Months)
-5.08%
EPS (1 Month)
1.07%
EPS (3 Months)
4.82%

Next Earnings Summary

ELV is expected to report earnings on 7/15/2026. The consensus EPS estimate for the next earnings is 6.51 USD and the consensus revenue estimate is 48.75B USD.
The next earnings revenue estimate has been revised downward by 5.08% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ELV revenue by date.ELV revenue by date.
171.34B
9.42%		176.81B
3.19%		199.125B
12.62%		194.84B
-2.15%		200.818B
3.07%		211.329B
5.23%		215.734B
2.08%		228.563B
5.95%		N/AN/AN/A
EBITDA
YoY % growth
ELV ebitda by date.ELV ebitda by date.
11.242B
10.60%		10.549B
-6.16%		9.658B
-8.45%		9.57B
-0.91%		10.402B
8.69%		11.286B
8.50%		13.25B
17.40%		14.088B
6.32%		15.058B
6.89%		16.119B
7.05%		17.274B
7.17%
EBIT
YoY % growth
ELV ebit by date.ELV ebit by date.
9.497B
11.86%		9.156B
-3.59%		8.112B
-11.40%		8.564B
5.57%		9.284B
8.41%		10.533B
13.45%		12.57B
19.34%		N/AN/AN/AN/A
Operating Margin
ELV operating margin by date.ELV operating margin by date.
5.54%5.18%4.07%4.40%4.62%4.98%5.83%N/AN/AN/AN/A
EPS
YoY % growth
ELV eps by date.ELV eps by date.
33.11
13.98%		32.97
-0.42%		30.17
-8.49%		26.17
-13.25%		29.55
12.89%		34.65
17.27%		41.39
19.47%		45.74
10.50%		49.04
7.21%		54.69
11.53%		61.35
12.17%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		6.51
-26.39%		5.46
-9.47%		3.21
-3.47%		12.04
-4.28%		7.47
14.77%		6.24
14.32%		4.08
27.00%		12.96
7.65%		7.66
2.51%		7.60
21.79%		4.42
8.36%
Revenue
Q2Q % growth		48.749B
-1.36%		49.033B
-2.10%		48.467B
-1.71%		48.749B
-1.51%		50.157B
2.89%		51.15B
4.32%		50.814B
4.84%		51.628B
5.91%		53.342B
6.35%		54.256B
6.07%		54.36B
6.98%
EBITDA
Q2Q % growth		2.36B
-30.30%		2.127B
-26.58%		1.361B
-36.01%		3.956B
7.33%		2.483B
5.21%		2.379B
11.85%		1.648B
21.09%		4.176B
5.56%		2.688B
8.26%		2.667B
12.11%		1.789B
8.56%
EBIT
Q2Q % growth		2.227B
-15.42%		1.909B
8.65%		1.149B
97.76%		3.568B
2.68%		2.193B
-1.53%		1.978B
3.61%		1.324B
15.23%		3.684B
3.25%		2.237B
2.01%		2.157B
9.05%		1.331B
0.53%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B 200B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
4.72%
EPS Next 5 Year
8.68%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1.81%
Revenue Next 5 Year
2.68%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
5.18%
EBIT Next 5 Year
7.75%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELEVANCE HEALTH INC / ELV Forecast FAQ

What do analysts expect the price target to be for ELEVANCE HEALTH INC (ELV)?

28 analysts have analysed ELV and the average price target is 391.79 USD. This implies a price increase of 13.64% is expected in the next year compared to the current price of 344.76.

Can you provide the upcoming earnings date for ELEVANCE HEALTH INC?

ELEVANCE HEALTH INC (ELV) will report earnings on 2026-07-15, before the market open.

What are the consensus estimates for ELEVANCE HEALTH INC (ELV) next earnings?

The consensus EPS estimate for the next earnings of ELEVANCE HEALTH INC (ELV) is 6.51 USD and the consensus revenue estimate is 48.75B USD.

What is the consensus rating for ELEVANCE HEALTH INC (ELV) stock?

The consensus rating for ELEVANCE HEALTH INC (ELV) is 74.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.